Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Hematology/Oncology Clinics of North America|August 31, 2020
Cell Cycle Dysregulation in Mantle Cell Lymphoma: Genomics and TherapyKevin Wang, Xiangao Huang, Maurizio Di Liberto, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 30, 2021
Caspase-8 Regulates the Antimyeloma Activity of Bortezomib and LenalidomideLiang Zhou, Xiangao Huang, Ruben Niesvizky, et al.
Annals of Lymphoma|August 13, 2020
Targeting CDK4/6 in mantle cell lymphomaChristina Lee, Xiangao Huang, Maurizio Di Liberto, et al.
Blood|December 18, 2010
Noxa mediates p18INK4c cell-cycle control of homeostasis in B cells and plasma cell precursorsJamieson Bretz, Josefina Garcia, Xiangao Huang, et al.
Frontiers in Cell and Developmental Biology|January 4, 2021
Caspase-8 Inhibition Prevents the Cleavage and Degradation of E3 Ligase Substrate Receptor Cereblon and Potentiates Its Biological FunctionLiang Zhou, Wenjun Yu, David S Jayabalan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 2, 2015
A novel effect of thalidomide and its analogs: suppression of cereblon ubiquitination enhances ubiquitin ligase functionYaobin Liu, Xiangao Huang, Xian He, et al.
Cancer Research|July 18, 2008
A novel therapeutic combination using PD 0332991 and bortezomib: study in the 5T33MM myeloma modelEline Menu, Josefina Garcia, Xiangao Huang, et al.
Leukemia & Lymphoma|May 24, 2019
A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphomaPeter Martin, Jia Ruan, Richard Furman, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
CDK4/6 Inhibition Reverses MEIS2 Suppression of CRL4 <sup>CRBN</sup> to Enhance Immunomodulatory Drug Therapy in Multiple MyelomaXiangao Huang, David Jayabalan, Maurizio Di Liberto, et al.
Cell Cycle (Georgetown, Tex.)|May 17, 2013
Induction of prolonged early G1 arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1David Chiron, Peter Martin, Maurizio Di Liberto, et al.
Pageof 3